Akebia Therapeutics Inc
AKBA2.800USD
+0.189+7.28%
收盤 05/19, 16:00（美東）報價延遲15分鐘
732.60M總市值
虧損本益比TTM
關於 Akebia Therapeutics Inc 公司
Akebia Therapeutics, Inc. 是一家完全整合的生物製藥公司。該公司專注於開發和商業化治療藥物。該公司的產品組合和基於缺氧誘導因子 (HIF) 的產品線包括 Auryxia（檸檬酸鐵）、Vafseo（vadadustat）、AKB-9090 和 AKB-10108。Auryxia（檸檬酸鐵）是一種口服藥物，已在美國獲批並上市，用於兩種適應症：控制透析依賴性慢性腎病 (DD-CKD) 成人患者的血清磷水平，以及治療非透析依賴性慢性腎病 (NDD-CKD) 成人患者的缺鐵性貧血 (IDA)。Vafseo（vadadustat）是一種 HIF 脯氨酰羥化酶 (HIF-PH) 抑制劑，已在 36 個國家獲批用於治療因慢性腎病 (CKD) 引起的貧血。它利用第三方進行 Auryxia 的商業分銷，包括批發分銷商和某些專業藥房供應商。
公司簡介
公司代碼AKBA
公司名稱Akebia Therapeutics Inc
上市日期Mar 20, 2014
成立日期2007
CEOMr. John P. Butler
員工數量181
證券類型Ordinary Share
年結日Mar 20
公司地址245 First Street
城市CAMBRIDGE
上市交易所NASDAQ Capital Market Consolidated
國家United States of America
郵編02142
電話16178712098
網址https://akebia.com/
公司代碼AKBA
上市日期Mar 20, 2014
成立日期2007
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Mr. John P. Butler
Mr. John P. Butler
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.68M
-17.18%
Mr. Adrian Adams
Mr. Adrian Adams
Independent Chairman of the Board
Independent Chairman of the Board
134.80K
--
Mr. Michael W. Rogers
Mr. Michael W. Rogers
Independent Director
Independent Director
96.03K
--
Ms. Cynthia Smith
Ms. Cynthia Smith
Independent Director
Independent Director
95.23K
--
Dr. Steven C. Gilman, Ph.D.
Dr. Steven C. Gilman, Ph.D.
Independent Director
Independent Director
87.13K
--
Dr. Myles Wolf, M.D.
Dr. Myles Wolf, M.D.
Independent Director
Independent Director
67.68K
--
Mr. Nicholas (Nik) Grund
Mr. Nicholas (Nik) Grund
Senior Vice President, Chief Commercial Officer
Senior Vice President, Chief Commercial Officer
45.48K
-89.72%
Ms. Leanne M. Zumwalt
Ms. Leanne M. Zumwalt
Independent Director
Independent Director
43.70K
--
Mr. Erik Ostrowski
Mr. Erik Ostrowski
Senior Vice President, Chief Financial Officer, Chief Business Officer, Treasurer
Senior Vice President, Chief Financial Officer, Chief Business Officer, Treasurer
--
-100.00%
Dr. Steven K. Burke, M.D.
Dr. Steven K. Burke, M.D.
Senior Vice President - Research and Development, Chief Medical Officer
Senior Vice President - Research and Development, Chief Medical Officer
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. John P. Butler
Mr. John P. Butler
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.68M
-17.18%
Mr. Adrian Adams
Mr. Adrian Adams
Independent Chairman of the Board
Independent Chairman of the Board
134.80K
--
Mr. Michael W. Rogers
Mr. Michael W. Rogers
Independent Director
Independent Director
96.03K
--
Ms. Cynthia Smith
Ms. Cynthia Smith
Independent Director
Independent Director
95.23K
--
Dr. Steven C. Gilman, Ph.D.
Dr. Steven C. Gilman, Ph.D.
Independent Director
Independent Director
87.13K
--
Dr. Myles Wolf, M.D.
Dr. Myles Wolf, M.D.
Independent Director
Independent Director
67.68K
--
收入明細
暫無數據
暫無數據
業務
地區
暫無數據
股東統計
更新時間: 5月17日 週六
更新時間: 5月17日 週六
持股股東
股東類型
持股股東
股東統計
佔比
BlackRock Institutional Trust Company, N.A.
5.32%
The Vanguard Group, Inc.
4.83%
State Street Global Advisors (US)
2.59%
Alerce Investment Management, L.P.
2.19%
Satter Muneer A
2.19%
Other
82.88%
持股股東
股東統計
佔比
BlackRock Institutional Trust Company, N.A.
5.32%
The Vanguard Group, Inc.
4.83%
State Street Global Advisors (US)
2.59%
Alerce Investment Management, L.P.
2.19%
Satter Muneer A
2.19%
Other
82.88%
股東類型
股東統計
佔比
Investment Advisor/Hedge Fund
15.41%
Hedge Fund
9.31%
Investment Advisor
8.54%
Individual Investor
3.52%
Private Equity
3.03%
Research Firm
2.48%
Bank and Trust
0.14%
Insurance Company
0.03%
Pension Fund
0.02%
Other
57.54%
機構持股
更新時間: 2月22日 週六
更新時間: 2月22日 週六
報告期間
機構數
持股數
持股佔比
持股變動
2025Q1
259
82.69M
31.59%
+8.81M
2024Q4
258
78.54M
36.08%
+7.41M
2024Q3
257
64.16M
30.51%
-2.18M
2024Q2
248
61.31M
29.27%
-7.52M
2024Q1
290
61.37M
29.36%
-12.30M
2023Q4
289
58.79M
31.24%
-20.79M
2023Q3
300
57.28M
30.45%
-25.18M
2023Q2
308
56.18M
30.22%
-26.52M
2023Q1
315
56.14M
30.23%
-26.40M
2022Q4
328
55.82M
30.36%
-25.38M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
BlackRock Institutional Trust Company, N.A.
13.84M
5.54%
-201.31K
-1.43%
Dec 31, 2024
The Vanguard Group, Inc.
10.88M
4.36%
+813.90K
+8.08%
Dec 31, 2024
State Street Global Advisors (US)
6.30M
2.52%
+2.87M
+83.78%
Dec 31, 2024
Alerce Investment Management, L.P.
5.75M
2.3%
--
--
Dec 31, 2024
Satter Muneer A
5.75M
2.3%
+5.75M
--
Dec 31, 2024
Geode Capital Management, L.L.C.
4.80M
1.92%
+40.63K
+0.85%
Dec 31, 2024
Renaissance Technologies LLC
3.82M
1.53%
+105.73K
+2.84%
Dec 31, 2024
Citadel Advisors LLC
1.38M
0.55%
+1.38M
--
Dec 31, 2024
查看更多
持股ETF
更新時間: 5月6日 週二
更新時間: 5月6日 週二
機構名稱
佔比
Invesco NASDAQ Future Gen 200 ETF
0.49%
Federated Hermes MDT Small Cap Core ETF
0.16%
iShares Micro-Cap ETF
0.09%
SPDR S&P Biotech ETF
0.08%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.08%
Direxion Daily S&P Biotech Bull 3X Shares
0.05%
Fidelity Enhanced Small Cap ETF
0.05%
iShares Russell 2000 Value ETF
0.03%
iShares Russell 2000 ETF
0.02%
Global X Russell 2000 ETF
0.02%
查看更多
Invesco NASDAQ Future Gen 200 ETF
佔比0.49%
Federated Hermes MDT Small Cap Core ETF
佔比0.16%
iShares Micro-Cap ETF
佔比0.09%
SPDR S&P Biotech ETF
佔比0.08%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
佔比0.08%
Direxion Daily S&P Biotech Bull 3X Shares
佔比0.05%
Fidelity Enhanced Small Cap ETF
佔比0.05%
iShares Russell 2000 Value ETF
佔比0.03%
iShares Russell 2000 ETF
佔比0.02%
Global X Russell 2000 ETF
佔比0.02%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
